{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:29:25Z","timestamp":1794626965823,"version":"4.9.1"},"reference-count":109,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Vaccination is the best way to prevent and reduce the damage caused by infectious diseases in animals and humans. So, several vaccines are used for prophylactic purposes before the pathogen infects, while therapeutic vaccines strengthen the immune system after infection with the pathogen. Adjuvants are molecules, compounds, or macromolecules that enhance non-specific immunity and, in collaboration with antigen(s), can improve the body\u2019s immune responses and change the type of immune response. The potential and toxicity of adjuvants must be balanced to provide the safest stimulation with the fewest side effects. In order to overcome the limitations of adjuvants and the effective and controlled delivery of antigens, attention has been drawn to nano-carriers that can be a promising platform for better presenting and stimulating the immune system. Some studies show that nanoparticles have a more remarkable ability to act as adjuvants than microparticles. Because nano-adjuvants inactively target antigen-presenting cells (APCs) and change their chemical surface, nanoparticles also perform better in targeted antigen delivery because they cross biological barriers more easily. We collected and reviewed various types of nano-adjuvants with their specific roles in immunogenicity as a prominent strategy used in veterinary vaccines in this paper.<\/jats:p>","DOI":"10.3390\/vaccines11020453","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T02:28:27Z","timestamp":1676514507000},"page":"453","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Immunogenicity of Different Types of Adjuvants and Nano-Adjuvants in Veterinary Vaccines: A Comprehensive Review"],"prefix":"10.3390","volume":"11","author":[{"given":"Soren","family":"Nooraei","sequence":"first","affiliation":[{"name":"Faculty of Veterinary Medicine, Shahrekord University, Shahrekord 8818634141, Iran"},{"name":"Animal Model Integrated Network (AMIN), Universal Scientific Education and Research Network (USERN), Tehran 1419733151, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9688-3554","authenticated-orcid":false,"given":"Alireza","family":"Sarkar Lotfabadi","sequence":"additional","affiliation":[{"name":"Animal Model Integrated Network (AMIN), Universal Scientific Education and Research Network (USERN), Tehran 1419733151, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1887-4526","authenticated-orcid":false,"given":"Milad","family":"Akbarzadehmoallemkolaei","sequence":"additional","affiliation":[{"name":"Animal Model Integrated Network (AMIN), Universal Scientific Education and Research Network (USERN), Tehran 1419733151, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3836-1827","authenticated-orcid":false,"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Animal Model Integrated Network (AMIN), Universal Scientific Education and Research Network (USERN), Tehran 1419733151, Iran"},{"name":"Research Center for Immunodeficiencies, Children\u2019s Medical Center, Tehran University of Medical Sciences, Dr. Gharib St, Keshavarz Blvd, Tehran 1419733151, Iran"},{"name":"Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran 1417653761, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"ref_1","first-page":"276","article-title":"Adjuvants and their mechanisms of action","volume":"12","author":"Foumani","year":"2012","journal-title":"J. Ardabil Univ. Med. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/CMR.00005-07","article-title":"Current status of veterinary vaccines","volume":"20","author":"Meeusen","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.coi.2011.04.005","article-title":"Systems biology approaches to new vaccine development","volume":"23","author":"Oberg","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nri3085","article-title":"Vaccines for the twenty-first century society","volume":"11","author":"Rappuoli","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Cappellano, G., Abreu, H., Casale, C., Dianzani, U., and Chiocchetti, A. (2021). Nano-Microparticle Platforms in Developing Next-Generation Vaccines. Vaccines, 9.","DOI":"10.3390\/vaccines9060606"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cvsm.2010.02.001","article-title":"Vaccines in veterinary medicine: A brief review of history and technology","volume":"40","author":"McVey","year":"2010","journal-title":"Vet. Clin. Small Anim. Pract."},{"key":"ref_7","first-page":"63","article-title":"On a new method of producing immunity from contagious diseases","volume":"10","author":"Salmon","year":"1886","journal-title":"Am. Vet. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0020-7519(03)00053-5","article-title":"Recent advances in veterinary vaccine adjuvants","volume":"33","author":"Singh","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"ref_9","unstructured":"WHO (2019). WHO Guide for Standardization of Economic Evaluations of Immunization Programmes, World Health Organization."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4110\/in.2013.13.5.177","article-title":"Nanoparticle-based vaccine delivery for cancer immunotherapy","volume":"13","author":"Park","year":"2013","journal-title":"Immune Netw."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.4161\/hv.29589","article-title":"Applications of nanomaterials as vaccine adjuvants","volume":"10","author":"Zhu","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants\u2014A classification and review of their modes of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/tvjl.2001.0663","article-title":"Vaccination: A management tool in veterinary medicine","volume":"164","author":"Babiuk","year":"2002","journal-title":"Vet. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/156720109789000537","article-title":"Oral vaccine delivery--new strategies and technologies","volume":"6","author":"Simerska","year":"2009","journal-title":"Curr. Drug Deliv."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejps.2003.10.010","article-title":"Intestinal solute carriers: An overview of trends and strategies for improving oral drug absorption","volume":"21","author":"Steffansen","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v24.i1.30","article-title":"Oral colon-specific drug delivery of protein and peptide drugs","volume":"24","author":"Sinha","year":"2007","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Adams, L.G., Babiuk, L., McGavin, D., and Nordgren, R. (2009). Special issues around veterinary vaccines. Vaccines Biodef. Emerg. Negl. Dis., 225.","DOI":"10.1016\/B978-0-12-369408-9.00016-0"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/j.vaccine.2009.01.084","article-title":"Mechanism of action of licensed vaccine adjuvants","volume":"27","author":"Tritto","year":"2009","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0002-9440(10)61232-1","article-title":"Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus","volume":"167","author":"Musser","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Franke, R., M\u00fcller, M., Wundrack, N., Gilles, E.-D., Klamt, S., K\u00e4hne, T., and Naumann, M. (2008). Host-pathogen systems biology: Logical modelling of hepatocyte growth factor and Helicobacter pylori induced c-Met signal transduction. BMC Syst. Biol., 2.","DOI":"10.1186\/1752-0509-2-4"},{"key":"ref_21","first-page":"71","article-title":"Formulation and Delivery Technologies for mRNA Vaccines","volume":"440","author":"Zeng","year":"2020","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"118731","DOI":"10.1016\/j.ijpharm.2019.118731","article-title":"Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines","volume":"572","author":"Jin","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nrmicro1681","article-title":"The perfect mix: Recent progress in adjuvant research","volume":"5","author":"Guy","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1389-0344(01)00101-0","article-title":"Recent developments in adjuvants for vaccines against infectious diseases","volume":"18","author":"MacKichan","year":"2001","journal-title":"Biomol. Eng."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1016\/j.vaccine.2011.08.089","article-title":"Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions","volume":"29","author":"Fox","year":"2011","journal-title":"Vaccine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.vaccine.2011.01.011","article-title":"Adjuvant System AS03 containing alpha-tocopherol modulates innate immune response and leads to improved adaptive immunity","volume":"29","author":"Morel","year":"2011","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1073\/pnas.0804699105","article-title":"Molecular and cellular signatures of human vaccine adjuvants","volume":"105","author":"Mosca","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: A review on adjuvants in licensed vaccines","volume":"39","author":"Rappuoli","year":"2018","journal-title":"Semin. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"682286","DOI":"10.3389\/fphar.2021.682286","article-title":"Nano and microparticles as potential oral vaccine carriers and adjuvants against infectious diseases","volume":"12","author":"Jazayeri","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/vim.2017.0049","article-title":"Adjuvants for animal vaccines","volume":"31","author":"Burakova","year":"2018","journal-title":"Viral Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"589833","DOI":"10.3389\/fimmu.2020.589833","article-title":"Adjuvants for Coronavirus Vaccines","volume":"11","author":"Liang","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_33","first-page":"1","article-title":"Vaccine adjuvants: Past, current and future","volume":"20","author":"Golian","year":"2018","journal-title":"J. Gorgan Univ. Med. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1016\/j.vaccine.2013.09.061","article-title":"Protein coated microcrystals formulated with model antigens and modified with calcium phosphate exhibit enhanced phagocytosis and immunogenicity","volume":"32","author":"Jones","year":"2014","journal-title":"Vaccine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1183\/09031936.00047111","article-title":"NiO and Co3O4 nanoparticles induce lung DTH-like responses and alveolar lipoproteinosis","volume":"39","author":"Cho","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/jphp.12352","article-title":"Particulate inorganic adjuvants: Recent developments and future outlook","volume":"67","author":"Maughan","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1586\/14760584.6.5.699","article-title":"MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection","volume":"6","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1586\/erv.09.5","article-title":"Emulsion-based adjuvants for influenza vaccines","volume":"8","author":"Vogel","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_39","unstructured":"Aucouturier, J., and Ganne, V. (2000, January 20\u201324). Assessment of oil adjuvants in Newcastle disease vaccine. Proceedings of the 20th World Poultry Congress, Montreal, QC, Canada."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1517\/14712591003724662","article-title":"MF59-adjuvanted vaccine: A safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk","volume":"10","author":"Durando","year":"2010","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1002\/1521-4141(2001010)31:10<2910::AID-IMMU2910>3.0.CO;2-3","article-title":"Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis","volume":"31","author":"Dupuis","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.vaccine.2010.12.090","article-title":"Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes","volume":"29","author":"Calabro","year":"2011","journal-title":"Vaccine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: Putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/14760584.2013.811188","article-title":"An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants","volume":"12","author":"Fox","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1586\/erv.11.48","article-title":"Current adjuvants and new perspectives in vaccine formulation","volume":"10","author":"Montomoli","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"20120536","DOI":"10.1098\/rsif.2012.0536","article-title":"Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases","volume":"10","author":"Shakya","year":"2013","journal-title":"J. R. Soc. Interface"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Fleck, J.D., Betti, A.H., da Silva, F.P., Troian, E.A., Olivaro, C., Ferreira, F., and Verza, S.G. (2019). Saponins from Quillaja saponaria and Quillaja brasiliensis: Particular Chemical Characteristics and Biological Activities. Molecules, 24.","DOI":"10.3390\/molecules24010171"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.vaccine.2005.07.105","article-title":"Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL\/6 mice","volume":"24","author":"Prater","year":"2006","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1016\/j.vaccine.2007.01.111","article-title":"Vaccine adjuvants revisited","volume":"25","author":"Aguilar","year":"2007","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1939-1676.2003.tb02448.x","article-title":"Adjuvants in veterinary vaccines: Modes of action and adverse effects","volume":"17","author":"Spickler","year":"2003","journal-title":"J. Vet. Intern. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1084\/jem.167.2.700","article-title":"Granulocyte\/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells","volume":"167","author":"Heufler","year":"1988","journal-title":"J. Exp. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: Current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cvsm.2017.10.002","article-title":"Recent Advances in Vaccine Technologies","volume":"48","author":"Francis","year":"2018","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.breast.2007.07.027","article-title":"Cognitive side-effects of adjuvant treatments","volume":"16","author":"Burstein","year":"2007","journal-title":"Breast"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00705-010-0863-1","article-title":"Adjuvants and delivery systems in veterinary vaccinology: Current state and future developments","volume":"156","author":"Heegaard","year":"2011","journal-title":"Arch. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvants\u2014A balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.toxlet.2011.03.001","article-title":"Progress in understanding adjuvant immunotoxicity mechanisms","volume":"203","author":"Lindblad","year":"2011","journal-title":"Toxicol. Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2217\/imt.14.81","article-title":"Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?","volume":"6","author":"Shaw","year":"2014","journal-title":"Immunotherapy"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Nohynek, H., Jokinen, J., Partinen, M., Vaarala, O., Kirjavainen, T., Sundman, J., Himanen, S.-L., Hublin, C., Julkunen, I., and Ols\u00e9n, P. (2012). AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033536"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Park, H.-J., Ko, H.L., Won, D.-H., Hwang, D.-B., Shin, Y.-S., Kwak, H.-W., Kim, H.-J., Yun, J.-W., and Nam, J.-H. (2019). Comprehensive analysis of the safety profile of a single-stranded RNA nano-structure adjuvant. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11090464"},{"key":"ref_61","first-page":"1668","article-title":"Inflammasomes and their role in diseases","volume":"32","author":"Tavassoli","year":"2014","journal-title":"J. Isfahan Med. Sch."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.4049\/jimmunol.0900164","article-title":"Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity","volume":"183","author":"McKee","year":"2009","journal-title":"J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4615-1823-5_7","article-title":"A compendium of vaccine adjuvants and excipients","volume":"6","author":"Vogel","year":"1995","journal-title":"Pharm. Biotechnol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1189\/jlb.0607392","article-title":"Pivotal advance: Eosinophils mediate early alum adjuvant-elicited B cell priming and IgM production","volume":"83","author":"Wang","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.immuni.2011.03.019","article-title":"Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms","volume":"34","author":"Kuroda","year":"2011","journal-title":"Immunity"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/eji.1830260915","article-title":"In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund\u2019s complete adjuvant, but continues to induce T helper 2 cytokine production","volume":"26","author":"Brewer","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1073\/pnas.1012455108","article-title":"Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59","volume":"108","author":"Ellebedy","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"11169","DOI":"10.1073\/pnas.1107941108","article-title":"Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88","volume":"108","author":"Seubert","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3762\/bjnano.9.98","article-title":"Review on nanoparticles and nanostructured materials: History, sources, toxicity and regulations","volume":"9","author":"Jeevanandam","year":"2018","journal-title":"Beilstein J. Nanotechnol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Lengyel, M., K\u00e1llai-Szab\u00f3, N., Antal, V., Laki, A.J., and Antal, I. (2019). Microparticles, microspheres, and microcapsules for advanced drug delivery. Sci. Pharm., 87.","DOI":"10.3390\/scipharm87030020"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"19902","DOI":"10.1073\/pnas.1313152110","article-title":"Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose","volume":"110","author":"Ballester","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","unstructured":"Tomai, M.A., and Vasilakos, J.P. (2013). Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines, Springer."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1016\/j.vaccine.2006.06.021","article-title":"Nano-and microparticles as adjuvants in vaccine design: Success and failure is related to host natural antibodies","volume":"24","author":"Sinyakov","year":"2006","journal-title":"Vaccine"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"387023","DOI":"10.1155\/2013\/387023","article-title":"Chitin, chitosan, and glycated chitosan regulate immune responses: The novel adjuvants for cancer vaccine","volume":"2013","author":"Li","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.3389\/fimmu.2018.02224","article-title":"Nanoparticle Vaccines Against Infectious Diseases","volume":"9","author":"Pati","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"eaaw6071","DOI":"10.1126\/sciadv.aaw6071","article-title":"A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer","volume":"6","author":"Ni","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/21645515.2015.1102804","article-title":"Peptide\/protein vaccine delivery system based on PLGA particles","volume":"12","author":"Allahyari","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1021\/ar300031y","article-title":"Physicochemical properties determine nanomaterial cellular uptake, transport, and fate","volume":"46","author":"Zhu","year":"2013","journal-title":"Acc. Chem. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejpb.2003.09.006","article-title":"Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice","volume":"57","author":"Vila","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.smim.2017.09.011","article-title":"Effects of engineered nanoparticles on the innate immune system","volume":"34","author":"Liu","year":"2017","journal-title":"Semin. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Carabineiro, S.A.C. (2017). Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines. Molecules, 22.","DOI":"10.3390\/molecules22050857"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Marslin, G., Siram, K., Maqbool, Q., Selvakesavan, R.K., Kruszka, D., Kachlicki, P., and Franklin, G. (2018). Secondary Metabolites in the Green Synthesis of Metallic Nanoparticles. Materials, 11.","DOI":"10.3390\/ma11060940"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.2147\/IJN.S109098","article-title":"Green synthesis and evaluation of silver nanoparticles as adjuvant in rabies veterinary vaccine","volume":"11","author":"Asgary","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Cappellano, G., Comi, C., Chiocchetti, A., and Dianzani, U. (2019). Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20010204"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e1600519","DOI":"10.1126\/sciadv.1600519","article-title":"Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles","volume":"2","author":"Pakulska","year":"2016","journal-title":"Sci. Adv."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1800362","DOI":"10.1002\/mabi.201800362","article-title":"Cross-Platform Comparison of Therapeutic Delivery from Multilamellar Lipid-Coated Polymer Nanoparticles","volume":"19","author":"Frizzell","year":"2019","journal-title":"Macromol. Biosci."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Ways, T.M.M., Lau, W.M., and Khutoryanskiy, V.V. (2018). Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems. Polymers, 10.","DOI":"10.3390\/polym10030267"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2147\/IJN.S238445","article-title":"Oral deliverable mucoadhesive Chitosan-Salmonella subunit nanovaccine for layer chickens","volume":"15","author":"Renu","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5482087","DOI":"10.1155\/2016\/5482087","article-title":"Mucosal Vaccine Development Based on Liposome Technology","volume":"2016","author":"Bernasconi","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Attia, M., Essa, E.A., Zaki, R.M., and Elkordy, A.A. (2020). An Overview of the Antioxidant Effects of Ascorbic Acid and Alpha Lipoic Acid (in Liposomal Forms) as Adjuvant in Cancer Treatment. Antioxidants, 9.","DOI":"10.3390\/antiox9050359"},{"key":"ref_92","unstructured":"Paoietti, R., and Kritchevsky, D. (1963). Advances in Lipid Research, Academic Press."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.apsb.2018.06.005","article-title":"Adapting liposomes for oral drug delivery","volume":"9","author":"He","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Bulbake, U., Doppalapudi, S., Kommineni, N., and Khan, W. (2017). Liposomal formulations in clinical use: An updated review. Pharmaceutics, 9.","DOI":"10.3390\/pharmaceutics9020012"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s11095-014-1419-y","article-title":"Biomaterials for nanoparticle vaccine delivery systems","volume":"31","author":"Sahdev","year":"2014","journal-title":"Pharm. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1039\/C6TB01131D","article-title":"Nanomaterial-Based Vaccine Adjuvants","volume":"4","author":"Sun","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/10717544.2010.483254","article-title":"Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides","volume":"17","author":"Mata","year":"2010","journal-title":"Drug Deliv."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/mp060096p","article-title":"Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: Formulation of a model vaccine for respiratory syncytial virus","volume":"4","author":"Mottram","year":"2007","journal-title":"Mol. Pharm."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcimb.2013.00013","article-title":"Vaccine delivery using nanoparticles","volume":"3","author":"Gregory","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/14760584.4.2.185","article-title":"Nanoparticles as carriers for nasal vaccine delivery","volume":"4","author":"Alonso","year":"2005","journal-title":"Expert Rev. Vaccines"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4155\/tde-2016-0008","article-title":"Vaccine delivery: Where polymer chemistry meets immunology","volume":"7","author":"Shae","year":"2016","journal-title":"Ther. Deliv."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coi.2010.01.022","article-title":"Intracellular mechanisms of antigen cross presentation in dendritic cells","volume":"22","author":"Amigorena","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"ref_104","first-page":"1061","article-title":"Immunologic adjuvants: An overview of Toll-like receptors mechanism of action in triggering the immune responses","volume":"61","author":"Rashidi","year":"2018","journal-title":"Med. J. Mashhad Univ. Med. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4161\/hv.27332","article-title":"Recent progress in adjuvant discovery for peptide-based subunit vaccines","volume":"10","author":"Azmi","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/2213529402666160601125159","article-title":"Targeting pattern recognition receptors (PRRs) in nano-adjuvants: Current perspectives","volume":"2","author":"Haghparast","year":"2016","journal-title":"Curr. Bionanotechnol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2018.09.008","article-title":"Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy","volume":"185","author":"Duong","year":"2018","journal-title":"Biomaterials"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2009.07.066","article-title":"Novel immunoadjuvants based on cationic lipid: Preparation, characterization and activity in vivo","volume":"27","author":"Lincopan","year":"2009","journal-title":"Vaccine"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4161\/hv.26796","article-title":"Polymeric nanoparticles: Potent vectors for vaccine delivery targeting cancer and infectious diseases","volume":"10","author":"Bolhassani","year":"2014","journal-title":"Hum. Vaccines Immunother."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/2\/453\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:37:25Z","timestamp":1760121445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/2\/453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":109,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["vaccines11020453"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11020453","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]}}}